ribosomal protein L7a pseudogene 50 (RPL7AP50)

RPL7AP50, or ribosomal protein L7a pseudogene 50, is a processed pseudogene related to the ribosomal protein L7a (RPL7A) gene. It is one of numerous pseudogenes in the human genome that originated from the functional RPL7A gene, which encodes a component of the large (60S) ribosomal subunit that catalyzes protein synthesis in eukaryotic cells[1][3][5]. Unlike its parent gene, this pseudogene does not produce a functional ribosomal protein and is not believed to have direct biological or pharmacological importance. There is no evidence linking RPL7AP50 to drug interactions, therapeutic mechanisms, or disease roles, and it is not regarded as a therapeutic target or biomarker. Its main relevance is as a genomic remnant that reflects the duplication and evolutionary dynamics of ribosomal protein genes in the genome[1][5]. Pseudogenes such as RPL7AP50 generally lack protein-coding potential and do not encode the active ribosomal protein L7a. While ribosomal protein L7a (RPL7A) itself is a well-characterized component of the ribosome, RPL7AP50 is only a nonfunctional pseudogene copy[3][5]. Some ribosomal protein pseudogenes in general may have regulatory RNA functions or rare associations with expression profiles, but there is no specific evidence for functional roles or clinical relevance for RPL7AP50[2][4][5]. If a therapeutic or biological function is sought, information should focus on the parent gene and protein: ribosomal protein L7a (RPL7A), not the pseudogene RPL7AP50[3][1].

Other names

RPL7A_23_1048RPL7AP50